Atlantic Coastal Acquisition Ii's

The company operates in the biotechnology and biopharmaceutical industries, with a focus on immuno-oncology and ophthalmology. Its competitors include large biopharmaceutical firms, specialty biotechnology companies, academic research departments, and public and private research institutions developing potentially competitive products and technologies. In immune-based cancer treatments such as T-cell engager, CAR T, and TCR therapies, competitors include Amgen, Bristol-Myers Squibb Company, Janux, J&J, Genentech, Inc. (a member of the Roche Group), Vir Bio, and Xencor. In ophthalmology-related treatments, competitors include Allergan plc, Genentech/Roche, Novartis International AG, and Regeneron Pharmaceuticals, Inc. Many of these competitors possess substantially greater financial, technical, and human resources, which may enhance their ability to obtain regulatory approvals and achieve market acceptance. Additionally, merger and acquisition activity in the industry may concentrate resources among fewer competitors.